Comparison of Short-Term Outcomes for Standard Versus Nonstandard Induction Dosing of Infliximab for Pediatric Inflammatory Bowel Disease
Nasab, Arian S., Finkler, Michael, DeLozier, Sarah, Sferra, Thomas J., Splawski, Judy, Moses, Jonathan
Published in The journal of pediatric pharmacology and therapeutics (01.01.2022)
Published in The journal of pediatric pharmacology and therapeutics (01.01.2022)
Get full text
Journal Article
Sa558 OVERALL RATE AND PREDICTIVE FACTORS FOR DURABILITY OF INFLIXIMAB IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS AT 3 AND 5 YEARS: A SINGLE CENTER EXPERIENCE
Siegel, Jaclyn, Siegel, Brittany, Nasab, Arian, Minich, Nori, Finkler, Michael D., Moses, Jonathan
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2021)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2021)
Get full text
Journal Article
Mo1910 SAFETY AND EFFICACY OF SUPRATHERAPEUTIC SERUM INFLIXIMAB LEVELS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
Swamy, Supraja S., Nasab, Arian, Malay, Sindhoosha, Perry, Sharon, Splawski, Judy B., Finkler, Michael D., Moses, Jonathan
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2020)
Published in Gastroenterology (New York, N.Y. 1943) (01.05.2020)
Get full text
Journal Article